等待開盤 12-12 09:30:00 美东时间
-1.230
-1.32%
今日重点评级关注:Chardan Capital:维持Senti Biosciences"买入"评级,目标价从12美元升至13美元;Guggenheim:维持Praxis Precision Medicine"买入"评级,目标价从540美元升至760美元
12-10 10:33
Descartes Systems Group Inc. announced it has received Toronto Stock Exchange (TSX) approval to launch a Normal Course Issuer Bid (NCIB) to repurchase up to 8,568,582 common shares, representing approximately 10% of its public float, on or before December 10, 2026. Repurchases will be made in the open market at management's discretion, subject to TSX rules. The maximum daily purchase limit on the TSX is 51,176 shares, excluding block purchases. F...
12-09 11:45
今日重点评级关注:摩根士丹利:维持Kyverna Therapeutics"超配"评级,目标价从20美元升至25美元;Maxim Group:维持Capricor Therapeutics"买入"评级,目标价从25美元升至50美元
12-05 08:35
BMO Capital analyst Thanos Moschopoulos maintains Descartes Systems Group (NASDAQ:DSGX) with a Market Perform and lowers the price target from $113 to $95.
12-04 22:17
The Descartes Systems Group Inc. ( ($DSGX) ) has released its Q3 earnings. Here...
12-04 11:52
Descartes Systems Gr (NASDAQ:DSGX) reported quarterly earnings of $0.50 per share which beat the analyst consensus estimate of $0.45 by 10.62 percent. This is a 19.05 percent increase over earnings of $0.42 per share
12-04 06:01
Companies Reporting Before The Bell • Yuanbao (NASDAQ:YB) is likely to report e...
12-03 19:11
Descartes Systems Gr (NASDAQ:DSGX) is preparing to release its quarterly earnin...
12-02 23:01
今日重点评级关注:Ascendiant Capital:维持Aclarion"买入"评级,目标价从22美元升至23美元;HC Wainwright & Co.:维持Cullinan Therapeutics"买入"评级,目标价从24美元升至26美元
11-21 15:50
Morgan Stanley analyst Chris Quintero maintains Descartes Systems Group (NASDAQ:DSGX) with a Equal-Weight and lowers the price target from $110 to $100.
11-20 23:27